Found 23 matching trials
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC PHASE2 This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Show More Location
Multiple Locations
Learn More & Join Trial
Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma PHASE1 The purpose of this study was to evaluate the safety and tolerability of lo...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
GIOTRIF rPMS in Korean Patients With NSCLC N/A To monitor the safety profile and efficacy of GIOTRIF® (afatinib dimaleate,...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus PHASE1 Evaluation of the safety and tolerability of immune-targeted therapy combin...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer PHASE1 This study sets out to determine the maximum tolerated dose (MTD) of afatin...
Show More Location
Ludwig-Maximilians - University of Munich
Learn More & Join Trial
Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC PHASE2 To explore the efficiency and safety of TP chemotherapy, tislelizumab, comb...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients PHASE2 The purpose of this study is to examine the efficacy and safety of using af...
Show More Location
Royal Bournemouth Hospital
Learn More & Join Trial
A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients. PHASE2 This study aimed to compare the efficacy of neoadjuvant low-dose radiothera...
Show More Location
Department of Radiation Oncology
Learn More & Join Trial
To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion PHASE4 This is an open-label, sing-arm, phase IV clinical study. The study is desi...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma PHASE1 This study is an exploratory clinical trial and does not involve statistica...
Show More Location
Multiple Locations
Learn More & Join Trial